Tina M Kish-Catalone

Mouse Model of Cervicovaginal Toxicity and Inflammation for Preclinical Evaluation of Topical Vaginal Microbicides

F. Krebs, B. Wigdahl, M. Howett, 2004, Antimicrobial Agents and Chemotherapy.

Preclinical Evaluation of Synthetic −2 RANTES as a Candidate Vaginal Microbicide To Target CCR5

Wuyuan Lu, R. Gallo, A. Devico, 2006, Antimicrobial Agents and Chemotherapy.

Cervicovaginal Safety of the Formulated, Biguanide-Based Human Immunodeficiency Virus Type 1 (HIV-1) Inhibitor NB325 in a Murine Model

F. Krebs, B. Wigdahl, M. Labib, 2011, Journal of biomedicine & biotechnology.

Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.

M. Reitz, R. Gallo, R. Pal, 2007, AIDS research and human retroviruses.

Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G.

F. Krebs, D. Malamud, B. Wigdahl, 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.